FierceBiotech ١٩ مايو ٢٠٢٦ Relay ‘full steam ahead’ on PI3K inhibitor fueled by first phase 2 data in blood vessel disorder
Endpoints News ١٩ مايو ٢٠٢٦ BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test
Revvity ١٩ مايو ٢٠٢٦ Revvity (RVTY) Is Down 5.0% After Raising 2026 Outlook And Securing FDA Assay Clearance - Sahm
Abbott ١٩ مايو ٢٠٢٦ Abbott Laboratories stock (US0028241000): steady momentum after latest earnings and diabetes tech pu - AD HOC NEWS
10x Genomics Blog ١٩ مايو ٢٠٢٦ 10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
Vertex ١٩ مايو ٢٠٢٦ Vertex Pharma stock (US92532F1003): cystic fibrosis leader after solid quarterly results - AD HOC NEWS
Novo Nordisk ١٩ مايو ٢٠٢٦ BioStock launches Consensus Analysis – a new analytical format for Nordic life science - TradingView
Clinical OMICs ١٩ مايو ٢٠٢٦ FDA-Approved Asthma Drug Boosts Efficacy of Immunotherapy in Aggressive Cancers
10x Genomics Blog ١٩ مايو ٢٠٢٦ 10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
Eli Lilly ١٩ مايو ٢٠٢٦ Supreme Court Ruling Puts Eli Lilly Medicaid Compliance And Investor Risks In Focus - simplywall.st
Labiotech ١٩ مايو ٢٠٢٦ Reducing cell culture contamination: Why sterilisation validation matters in CO₂ shaking workflows
Edwards Lifesciences ١٩ مايو ٢٠٢٦ Edwards Lifesciences stock (US28176E1082): heart-valve specialist in focus after latest earnings upd - AD HOC NEWS
Charles River ١٩ مايو ٢٠٢٦ Charles River Laboratories stock (US1591881009): Fresh earnings and outlook keep investors focused o - AD HOC NEWS
Lonza News ١٩ مايو ٢٠٢٦ Lonza Group AG stock (CH0013841017): pharma supplier in focus after 2025 results and dividend decisi - AD HOC NEWS
GCC ١٩ مايو ٢٠٢٦ Gamechangers: AI | CARMA’s Mazen Nahawi sees the GCC becoming a global laboratory for applied AI - MSN
LabCorp ١٩ مايو ٢٠٢٦ Labcorp stock (US50540R4092): Q1 results, new contracts and healthcare demand in focus - AD HOC NEWS
Qiagen ١٩ مايو ٢٠٢٦ Qiagen N.V. stock (NL0012169213): diagnostics specialist updates investors after Q1 results - AD HOC NEWS